Please assess the completion status of the following clinical trial:

Trial Title: Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age ≥18 years~2. Approved for or supported with HeartWare durable LVAD~3. Capable of giving informed consent~Exclusion Criteria:~1. For those undergoing new device implantation:~   1. Age \<18 years~  2. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile 1 at the time of implantation~  3. Presence of intra-cardiac thrombus~  4. History of thromboembolic event within previous 3 months of enrollment~2. For those with prior LVAD implantation with on-going support:~   1. Support duration \<3 months~  2. History of prior LVAD pump exchange~  3. History of LVAD pump hemolysis or thrombosis as defined by INTERMACS criteria~  4. History of stroke or transient ischemic event within previous 3 months of enrollment~  5. History of post-LVAD severe right ventricular failure as defined by INTERMACS criteria within previous 3 months of enrollment~  6. History of pump-related infection treated within previous 3 months of enrollment or those on chronic antibiotics suppressive therapy for pump related infection~  7. History of post-LVAD intra-cardiac or arterial thrombus or thromboembolic event within previous 3 months of enrollment~  8. International Normalized Ratio (INR) \<2 within previous 30-days from the date of enrollment~  9. Aspirin dose \<325 mg/day~  10. Lactate Dehydrogenase (LDH) levels ≥ 3 times the upper normal limit in previous 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lavare Cycle On (Type: ACTIVE_COMPARATOR): For the patients randomized to Lavare On group, the Lavare™ cycle will be turned on upon device interrogation after patients return to intensive care unit from the operating room.
- Lavare Cycle Off (Type: ACTIVE_COMPARATOR): For the patients randomized to Lavare Off group, the Lavare™ cycle will be turned off upon device interrogation after patients return to intensive care unit from the operating room.

Based on this trial design, predict the completion outcome and termination type (if applicable).